Richard Chin Insider Trading $KIN Kindred Biosciences, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Richard Chin.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Richard Chin. Richard Chin is Director in OXIGENE INC ($OXGN) and President and CEO in OXIGENE INC ($OXGN) and Director in Galena Biopharma, Inc. ($GALE) and CEO in Kindred Biosciences, Inc. ($KIN) and Chief Executive Officer in Kindred Biosciences, Inc. ($KIN) and President & CEO in Kindred Biosciences, Inc. ($KIN) and President and CEO in Kindred Biosciences, Inc. ($KIN).

Richard Chin in Kindred Biosciences, Inc.

Trading Symbol: KIN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard Chin: Chief Executive Officer, President and CEO, President & CEO
Holdings: 1,980,853 shares
Current Value: $12,677,459
Latest Transaction: Feb 03 2021
$KIN Market Capitalization: $126.31M
$KIN Previous Close: $6.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Richard Chin in Kindred Biosciences, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, KIN, MATN, SLS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 03 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseM0.0012,500025,000
Feb 03 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF5.006,58232,9101,974,2712 M to 2 M (-0.33 %)
Feb 03 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...BuyM0.0012,50001,980,8532 M to 2 M (+0.64 %)
Jan 26 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseM0.0037,500037,500
Jan 26 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF4.9313,16364,8941,968,3532 M to 2 M (-0.66 %)
Jan 26 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF4.9319,74497,3381,981,5162 M to 2 M (-0.99 %)
Jan 26 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...BuyM0.0037,50002,001,2602 M to 2 M (+1.91 %)
Jan 20 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseA4.44394,0001,749,360394,000
Jan 20 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseM0.0037,5000112,500
Jan 20 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF4.9521,128104,5841,963,7602 M to 2 M (-1.06 %)
Jan 20 2021KINKindred Bioscience ...Chin RichardChief Executive Off ...BuyM0.0037,50001,984,8881.9 M to 2 M (+1.93 %)
Feb 13 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseM0.0012,500037,500
Feb 13 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF9.224,31739,8031,947,3882 M to 1.9 M (-0.22 %)
Feb 13 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...BuyM0.0012,50001,951,7051.9 M to 2 M (+0.64 %)
Jan 24 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseM0.0037,500075,000
Jan 24 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF9.668,64583,5111,939,2051.9 M to 1.9 M (-0.44 %)
Jan 24 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF9.8811,607114,6771,947,8502 M to 1.9 M (-0.59 %)
Jan 24 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...BuyM0.0037,50001,959,4571.9 M to 2 M (+1.95 %)
Jan 22 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseA0.00150,0000150,000
Jan 22 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseA9.84300,0002,952,000300,000
Jan 22 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseA0.00150,0000150,000
Jan 22 2020KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseA9.84300,0002,952,000300,000
Feb 05 2019KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseA0.0050,000050,000
Feb 05 2019KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseA9.91400,0003,964,000400,000
Jan 24 2019KINKindred Bioscience ...Chin RichardChief Executive Off ...Option ExerciseM0.0037,5000112,500
Jan 24 2019KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF9.958,64685,9841,921,9571.9 M to 1.9 M (-0.45 %)
Jan 24 2019KINKindred Bioscience ...Chin RichardChief Executive Off ...Payment of ExerciseF10.1212,968131,2361,930,6031.9 M to 1.9 M (-0.67 %)
Jan 24 2019KINKindred Bioscience ...Chin RichardChief Executive Off ...BuyM0.0037,50001,943,5711.9 M to 1.9 M (+1.97 %)
Jan 04 2019KINKindred Bioscience ...Chin RichardChief Executive Off ...SellS10.5740,000422,7161,906,0711.9 M to 1.9 M (-2.06 %)
Dec 04 2018KINKindred Bioscience ...Chin RichardChief Executive Off ...SellS13.2840,000531,2001,946,0712 M to 1.9 M (-2.01 %)
Nov 02 2018KINKindred Bioscience ...Chin RichardCEOSellS14.6840,000587,2001,986,0712 M to 2 M (-1.97 %)
Oct 03 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS13.2840,000531,2002,026,0712.1 M to 2 M (-1.94 %)
Sep 06 2018KINKindred Bioscience ...Chin RichardPRESIDENT AND CEOSellS14.697,600111,6442,066,0712.1 M to 2.1 M (-0.37 %)
Sep 06 2018KINKindred Bioscience ...Chin RichardPRESIDENT AND CEOSellS14.8132,400479,8442,073,6712.1 M to 2.1 M (-1.54 %)
Aug 03 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS13.5140,000540,4002,106,0712.1 M to 2.1 M (-1.86 %)
Jun 01 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS10.1340,000405,2002,186,0712.2 M to 2.2 M (-1.80 %)
Jun 01 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS10.0012,610126,1002,226,0712.2 M to 2.2 M (-0.56 %)
May 29 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS10.003,00030,0002,238,6812.2 M to 2.2 M (-0.13 %)
May 29 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS10.00606002,241,6812.2 M to 2.2 M (0.00 %)
May 18 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS10.002,40024,0002,241,7412.2 M to 2.2 M (-0.11 %)
May 09 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS10.002002,0002,244,1412.2 M to 2.2 M (-0.01 %)
May 09 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS10.011,73017,3172,244,3412.2 M to 2.2 M (-0.08 %)
May 02 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS9.0520,000181,0002,246,0712.3 M to 2.2 M (-0.88 %)
Apr 04 2018KINKindred Bioscience ...Chin RichardPresident and CEOSellS8.3920,000167,8002,266,0712.3 M to 2.3 M (-0.87 %)
Jan 24 2018KINKindred Bioscience ...Chin RichardPresident and CEOOption ExerciseA0.00150,0000150,000
Jan 24 2018KINKindred Bioscience ...Chin RichardPresident and CEOOption ExerciseA8.75175,0001,531,250175,000
Jan 24 2018KINKindred Bioscience ...Chin RichardPresident and CEOPayment of ExerciseF9.1511,475104,9962,286,0712.3 M to 2.3 M (-0.50 %)
Jan 24 2018KINKindred Bioscience ...Chin RichardPresident and CEOOption ExerciseA0.00150,0000150,000
Jan 24 2018KINKindred Bioscience ...Chin RichardPresident and CEOOption ExerciseA8.75175,0001,531,250175,000
Jan 24 2018KINKindred Bioscience ...Chin RichardPresident and CEOPayment of ExerciseF9.1511,475104,9962,286,0712.3 M to 2.3 M (-0.50 %)
Jul 06 2017KINKindred Bioscience ...Chin RichardPresident and CEOSellS8.2613,000107,3802,297,5462.3 M to 2.3 M (-0.56 %)
Jun 26 2017KINKindred Bioscience ...Chin RichardPresident and CEOSellS7.7513,000100,7502,310,5462.3 M to 2.3 M (-0.56 %)
Jan 25 2017KINKindred Bioscience ...Chin RichardPresident & CEOOption ExerciseA6.40175,0001,120,000175,000
Jan 25 2017KINKindred Bioscience ...Chin RichardPresident & CEOGrantA0.00100,00002,323,5462.2 M to 2.3 M (+4.50 %)
Jan 25 2017KINKindred Bioscience ...Chin RichardPresident & CEOGiftG0.00400,00002,223,5462.6 M to 2.2 M (-15.25 %)
Jan 12 2016KINKindred Bioscience ...Chin RichardPresident & CEOOption ExerciseA3.45197,771682,310197,771

Page:   1

Contact us | Follow us on Twitter